| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 27, 2003
From the Department of Medicine, Skellefteå County Hospital, Skellefteå (L.J., J.-H.J., K.B.); Department of Public Health and Clinical Medicine (B.S., G.H.) and Medical Bank (G.H.), Umeå University Hospital, Umeå; and Department of Clinical Chemistry, Örebro University Hospital and Division of Biomedicine, Örebro University, Örebro (T.K.N.), Sweden. * To whom correspondence should be addressed. E-mail: lars.johansson.ss{at}vll.se.
Background and Purpose--Abnormalities in the hemostatic system may cause hemorrhagic complications. The aim of the present study was to examine whether total concentrations of tissue plasminogen activator (tPA), plasminogen inhibitor-1 (PAI-1), tPA/PAI-1 complex, von Willebrand factor (VWF), and soluble thrombomodulin were associated with a first-ever intracerebral hemorrhage (ICH). Methods--This prospective study was an incident case-referent study nested within the Västerbotten Intervention Program and the Northern Sweden Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) cohorts. By 2000, Results--The average time from screening to the ICH event was 5.1 years. tPA/PAI-1 complex, systolic and diastolic blood pressures, and hypertension were associated with ICH in the univariate analysis. In the multivariate model, only hypertension (odds ratio [OR], 3.96; 95% confidence interval [CI], 1.27 to 12.36) and the tertile with the highest level of VWF compared with the lowest tertile (OR, 0.27; 95% CI, 0.08 to 0.90) were independently associated with ICH. The OR for the combined exposure to hypertension and low levels of VWF was 8.95, indicating a possible synergistic interaction. No associations were observed for smoking, cholesterol, body mass index, PAI-1, tPA, and soluble thrombomodulin. Conclusions--This study showed that hypertension and low concentrations of VWF were independently associated with ICH. Furthermore, we observed a possible synergistic interaction between low levels of VWF and hypertension, suggesting 2 different pathways in the development of ICH.
Accepted on December 10, 2003
Hemostatic Factors as Risk Markers for Intracerebral Hemorrhage. A Prospective Incident Case-Referent Study
Lars Johansson MD, PhD*;
74 000 subjects had been screened, and 39 ICH cases were defined according to the World Health Organization MONICA criteria. A total of 78 matched controls were selected from the same cohort.
This article has been cited by other articles:
![]() |
J. D. Sturgeon, A. R. Folsom, W.T. Longstreth Jr, E. Shahar, W. D. Rosamond, and M. Cushman Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort Stroke, August 1, 2008; 39(8): 2268 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
Wei Hsi Chen, Hung Sheng Lin, and Y.-F. Kao Type II Cryoglobulinemia and Brain Hemorrhage Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 241 - 244. [Abstract] [PDF] |
||||
![]() |
S. Nilsson-Ardnor, P.-G. Wiklund, P. Lindgren, A. K. Nilsson, T. Janunger, S. A. Escher, B. Hallbeck, B. Stegmayr, K. Asplund, and D. Holmberg Linkage of Ischemic Stroke to the PDE4D Region on 5q in a Swedish Population Stroke, August 1, 2005; 36(8): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hanley and W. Hacke Critical Care and Emergency Medicine Neurology in Stroke Stroke, February 1, 2005; 36(2): 205 - 207. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |